Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02028338 · ClinicalTrials.gov registry record · Phase 2
Study of Dapivirine Vaginal Ring (VR) in Adolescents
A Phase 2 study, sponsored by International Partnership for Microbicides.
- Completed
- Registry status
- Phase 2
- Development phase
- 96
- Enrollment target
NCT02028338 is a Phase 2 study that has completed, run by International Partnership for Microbicides. The registered enrollment target is 96 participants.
The verdict
NCT02028338, a Phase 2 study, has completed, sponsored by International Partnership for Microbicides.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 96 participants
- Enrollment target
Study Summary
To assess the safety of dapivirine (25 mg) administered via a silicone vaginal ring in HIV-uninfected adolescent females, when inserted once every 4 weeks during 24-week of study product use.
Interventions
- COMBINATION_PRODUCT placebo ring
- COMBINATION_PRODUCT dapivirine ring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2014-06-27 |
| Est. Completion | 2018-06-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02028338
The ClinicalTrials.gov registry entry for NCT02028338 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is International Partnership for Microbicides, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo ring is the first listed.
NCT02028338 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02028338 about?
NCT02028338 is a clinical study titled "Study of Dapivirine Vaginal Ring (VR) in Adolescents". To assess the safety of dapivirine (25 mg) administered via a silicone vaginal ring in HIV-uninfected adolescent females, when inserted once every 4 weeks during 24-week of study product use.
What is the current status of trial NCT02028338?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 96 participants. The study started on 2014-06-27. Estimated completion is 2018-06-08.
What interventions are being tested in trial NCT02028338?
The interventions under investigation include: placebo ring (COMBINATION_PRODUCT), dapivirine ring (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT02028338?
This trial is sponsored by International Partnership for Microbicides, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.